Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Debt/Equity

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Total Debt/Equity(x) 0.210.180.100.230.33

What is the latest Total Debt/Equity ratio of AUROBINDO PHARMA ?

The latest Total Debt/Equity ratio of AUROBINDO PHARMA is 0.21 based on Mar2024 Consolidated results.
Year Total Debt/Equity
Mar20240.21
Mar20230.18
Mar20220.10
Mar20210.23
Mar20200.33

How is Total Debt/Equity of AUROBINDO PHARMA Trending?

Years Total Debt/Equity % Change
Mar2024 0.21
16.67
Mar2023 0.18
80.00
Mar2022 0.1
-56.52
Mar2021 0.23
-30.30
Mar2020 0.33 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Total Debt/Equity ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹66,829.8 Cr -0.9% -5.5% -7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.9%

-5.5%

-7.5%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses